Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1,570
-
Total 13F shares, excl. options
-
1,003,983,340
-
Shares change
-
+11,093,574
-
Total reported value, excl. options
-
$61,982,373,182
-
Value change
-
+$689,958,176
-
Put/Call ratio
-
76%
-
Number of buys
-
822
-
Number of sells
-
-621
-
Price
-
$61.69
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2022
1,741 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2022.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,570 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,003,983,340 shares
of 1,240,722,841 outstanding shares and own 81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (128,460,733 shares), VANGUARD GROUP INC (112,087,271 shares), STATE STREET CORP (59,240,350 shares), Capital World Investors (57,762,744 shares), Capital Research Global Investors (53,875,470 shares), Dodge & Cox (36,369,252 shares), GEODE CAPITAL MANAGEMENT, LLC (23,603,591 shares), Bank of New York Mellon Corp (15,421,435 shares), MORGAN STANLEY (15,416,461 shares), and NORTHERN TRUST CORP (15,301,618 shares).
This table shows the top 1,570 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.